Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.
06/27/22 • 37 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/hypertrophic-cardiomyopathy-podcast-series-518753/hcm-and-new-pharmacological-agents-67692430"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to hcm and new pharmacological agents on goodpods" style="width: 225px" /> </a>
Copy